シングルセルシーケンシング市場 – 2030年までの世界予測

この調査レポートでは、シングルセルシーケンシング市場を、提供内容（製品、サービス）、製品タイプ（消耗品（プレシーケンシング、シーケンシング）、機器（プレシーケンシング機器（マイクロフルイディクス、PCR、LCM、FAC、その他）、シーケンシングプラットフォーム）、ソフトウェア）、製品ワークフロー（プレシーケンシング、シーケンシング、ソフトウェア）、製品エンドユーザー（病院および診断ラボ、学術研究機関、製薬およびバイオテクノロジー企業、契約研究機関）、サービスタイプ（プレシーケンシングサービス（サンプル調製、ライブラリ調製）、シーケンシングサービス、バイオインフォマティクスサービス）、サービスエンドユーザー（病院および診断ラボ、学術研究機関、製薬およびバイオテクノロジー企業）、シーケンシングタイプ（シングルセルトランスクリプトームシーケンシング、シングルセルゲノムシーケンシング、シングルセルATACシーケンシング、その他）、アプリケーション（研究アプリケーション（基本研究分野（がん研究、幹細胞および発生生物学、神経学および脳研究、微生物学および感染症、臓器発達および再生医療）、創薬および開発、診断および臨床応用）を地域別（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）に分析しました。

本レポートは、シングルセルシーケンシング市場の成長に影響を与える重要な要因、すなわち成長促進要因、トレンド、課題、機会に関する詳細な情報を提供しています。主要業界プレーヤーを徹底的に分析し、それぞれの事業概要、製品／サービス、主要戦略、協業、パートナーシップ、契約に関する洞察を提供しています。さらに、本レポートでは、シングルセルシーケンシング市場における新製品の発売や買収といった最近の動向も網羅しています。

本レポートは、シングルセルシーケンシング市場全体とそのサブセグメントの収益数値を最も近似値で示すことで、市場リーダー／新規参入企業を支援します。また、ステークホルダーの皆様が競争環境をより深く理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。本レポートは、ステークホルダーの皆様が市場の動向を把握し、主要な市場牽引要因、制約要因、機会、課題に関する情報を提供することを可能にします。

シングルセルシーケンシング市場は、2025年の19億5,000万米ドルから2030年には34億6,000万米ドルに達し、予測期間中は年平均成長率（CAGR）12.2%で成長すると予測されています。この市場の成長は、シングルセルシーケンシング技術の継続的な技術進歩によるもので、これらの技術はより正確で、拡張性が高く、効率的になっています。例えば、2025年7月には、華中科技大学の研究者が、特殊なグリカン結合タンパク質を用いてあらゆる種類の細胞や核を標識することで、サンプルのマルチプレックス化や希少細胞の検出における課題を克服するToti-N-Seqプラットフォームを開発しました。同時に、10x GenomicsのChromiumのような確立されたシステムは、その信頼性、ハイスループット、そして幅広い普及により、広範な研究に不可欠な存在であり続けています。

The single-cell sequencing market is expected to reach USD 3.46 billion in 2030 from USD 1.95 billion in 2025, at a CAGR of 12.2% during the forecast period. The growth of this market can be attributed to ongoing technological advancements in single-cell sequencing technologies, which are becoming more accurate, scalable, and efficient. For instance, in July 2025, researchers from the Huazhong University of Science and Technology developed the Toti-N-Seq platform to overcome challenges in sample multiplexing and rare cell detection by using a special glycan-binding protein to label all types of cells and nuclei. At the same time, well-established systems like 10x Genomics’ Chromium remain essential for extensive studies due to their reliability, high throughput, and broad adoption.

“By type, the sequencing instruments segment is expected to register the highest growth rate during the forecast period.”

By type, the single-cell sequencing products market is segmented into consumables, instruments, and software. The instruments segment is further segmented into pre-sequencing and sequencing instruments. The sequencing instruments segment registered the highest CAGR during the forecast period. This growth is primarily driven by the emergence of new sequencing technology providers, such as Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Element Biosciences, and Ultima Genomics, that have introduced platforms compatible with various single-cell sequencing workflows. Additionally, sequencing instruments remain the core technological driver of single-cell sequencing, performing the essential function of decoding nucleic acids at single-cell resolution. As applications of single-cell sequencing expand into areas like oncology, immunology, neuroscience, and microbiome studies, there is a corresponding rise in demand for sequencing instruments capable of handling increasingly complex, large-scale datasets.

“By service type, the sequencing services segment accounted for the largest share of the market in 2024.”

Based on service type, the single-cell sequencing market is pre-sequencing services, sequencing services, and data analysis & bioinformatic services. In 2024, the sequencing services segment held the largest share of the single-cell sequencing market by service type. The large share of this service segment can be attributed to the high cost and operational complexity of sequencing instruments. The growing demand for clinical-grade sequencing, higher throughput, and standardized data output has also driven the expansion of professional sequencing services, reinforcing their leading position in the market. Moreover, with the rising adoption of single-cell technologies in translational research and clinical studies, sequencing services offer a scalable and compliant solution for handling large sample volumes.

“The Asia Pacific region is expected to grow at the highest CAGR in the single-cell sequencing market during the forecast period.”

The market is segmented by region into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is projected to register the highest CAGR in the single-cell sequencing market during the forecast period. The key factors driving the market growth include expanding biomedical research infrastructure, rising government funding, and increasing adoption of single-cell technologies in clinical and academic settings. Countries like China, Japan, and South Korea actively invest in genomics through national initiatives and grants. At the same time, companies such as Singleron Biotechnologies and Macrogen make the technology more accessible across research and diagnostic markets. The region’s large and genetically diverse populations offer vast opportunities for disease-specific single-cell studies, particularly in oncology and infectious diseases. Additionally, lower operational costs and growing outsourcing of sequencing services to Asia-based CROs further accelerate regional growth, making the Asia Pacific a key engine of expansion for the global single-cell sequencing market.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
• By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25%
• By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, and the Rest of the World- 15%

10x Genomics (US), Illumina Inc. (US), BD (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), Bio-Techne (US), and PacBio (US) are some of the key players in the single-cell sequencing market.

The study includes an in-depth competitive analysis of these key players in the single-cell sequencing market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

This research report categorizes the single cell sequencing market by offering (products, services), by product type (consumables [pre-sequencing, sequencing], instruments [pre-sequencing instruments {microfluidics, PCR, LCM, FACs, others}, sequencing platforms], software), by product workflow (pre-sequencing, sequencing, software), by product end user (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations), by service type (pre-sequencing services [sample preparation, library preparation], sequencing services, bioinformatics services), by service end users (hospitals & diagnostic laboratories, academic & research institutes, pharmaceutical & biotechnology companies), by sequencing type (single cell transciptome sequencing, single cell genome sequencing, single cell ATAC sequencing, others), by application (research application [basic & translation research {cancer research, stem cell & developmental biology, neurology & brain research, microbiology & infectious disease, organ development & regenerative medicine}, drug discovery & development], diagnostic & clinical application), by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The report provides in-depth information on significant factors influencing the growth of the single-cell sequencing market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products/services, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches and acquisitions within the single-cell sequencing market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-cell sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

• Analysis of key drivers (Advancements in Single-Cell sequencing technologies, Growing Demand for Personalized Medicine and Biomarker Discovery, Integration of AI and ML in data analysis, Advantages over bulk sequencing), restraints (High cost of single cell sequencing and analysis products), opportunities (Development of Sequencing by Expansion (SBX) technology, Growing clinical applications), and challenges (Data Complexities and Analysis Bottleneck) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products/services of the single-cell sequencing market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the single-cell sequencing market
• Competitive Assessment: In-depth assessment of market share, growth strategies and service offerings of leading players like 10x Genomics (US), Illumina Inc. (US), BD (US), Danaher (US), Thermo Fisher Scientific Inc. (US), Qiagen (Netherlands), and Pacbio (US) among others, in the single-cell sequencing market.

Table of Contents

1               INTRODUCTION              52

1.1           STUDY OBJECTIVES       52

1.2           MARKET DEFINITION   52

1.3           MARKET SCOPE                52

1.3.1        MARKETS & REGIONS COVERED               53

1.3.2        INCLUSIONS & EXCLUSIONS       54

1.3.3        YEARS CONSIDERED      56

1.3.4        CURRENCY CONSIDERED            56

1.4           MARKET STAKEHOLDERS            56

2               RESEARCH METHODOLOGY       57

2.1           RESEARCH DATA              57

2.1.1        SECONDARY DATA          58

2.1.2        PRIMARY DATA 59

2.2           MARKET ESTIMATION METHODOLOGY               60

2.2.1        MARKET SIZE ESTIMATION         60

2.2.2        SEGMENTAL MARKET ASSESSMENT       63

2.3           MARKET GROWTH RATE PROJECTIONS                65

2.4           DATA TRIANGULATION                68

2.5           RESEARCH ASSUMPTIONS           69

2.6           RESEARCH LIMITATIONS             70

2.7           RISK ASSESSMENT           71

3               EXECUTIVE SUMMARY  72

3.1           KEY INSIGHTS AND MARKET HIGHLIGHTS          72

3.2           STRATEGIC IMPERATIVES FOR STAKEHOLDERS                 79

3.3           DISRUPTIVE TRENDS SHAPING MARKET               80

4               PREMIUM INSIGHTS       81

4.1           SINGLE-CELL SEQUENCING MARKET SNAPSHOT                 81

4.2          NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING & COUNTRY (2024)              82

4.3           SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE (2024)                 82

4.4           SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER (2024)               83

4.5           SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER (2024)         83

4.6           SINGLE-CELL SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES         84

5               MARKET OVERVIEW       85

5.1           INTRODUCTION              85

5.2           MARKET DYNAMICS       85

5.2.1        DRIVERS               86

5.2.1.1    Advancements in single-cell sequencing technologies   86

5.2.1.2    Growing focus on precision medicine and biomarker discovery                 87

5.2.1.3    Integration of AI & ML in data analysis            88

5.2.1.4    Advantages over conventional bulk sequencing               88

5.2.2        RESTRAINTS      89

5.2.2.1    High cost of single-cell sequencing products & services                 89

5.2.3        OPPORTUNITIES              89

5.2.3.1    Emergence of SBX technology            89

5.2.3.2    Integration of multi-omics technologies           90

5.2.3.3    Growth potential of emerging economies         91

5.2.4        CHALLENGES    92

5.2.4.1    Complexities associated with high-dimensional single-cell data                 92

5.2.4.2    Biological variability and cell heterogeneity     92

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       92

5.4           VALUE CHAIN ANALYSIS               94

5.5           ECOSYSTEM ANALYSIS  96

5.5.1        EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT IN SINGLE-CELL SEQUENCING MARKET                98

5.6           TECHNOLOGY ANALYSIS             99

5.6.1        KEY TECHNOLOGIES     99

5.6.1.1    Microfluidics partitioning   99

5.6.1.2    NGS        99

5.6.1.3    PCR        99

5.6.1.4    Flow cytometry     100

5.6.2        COMPLEMENTARY TECHNOLOGIES       100

5.6.2.1    Magnetic-activated Cell Sorting (MACS)        100

5.6.2.2    Tissue dissociation systems 100

5.6.2.3    Combinatorial indexing       100

5.6.3        ADJACENT TECHNOLOGIES       101

5.6.3.1    Bulk RNA-seq       101

5.6.3.2    In situ hybridization (ISH) 101

5.7           PATENT ANALYSIS          101

5.7.1        PATENT METHODOLOGY            101

5.7.2        PATENTS APPLIED & GRANTED, 2014–2024           102

5.8           TRADE ANALYSIS             104

5.8.1        IMPORT DATA (HS CODE 9027) 104

5.8.2        EXPORT DATA (HS CODE 9027) 106

5.9           PORTER’S FIVE FORCES ANALYSIS           107

5.9.1        THREAT OF NEW ENTRANTS      109

5.9.2        THREAT OF SUBSTITUTES          109

5.9.3        BARGAINING POWER OF SUPPLIERS       109

5.9.4        BARGAINING POWER OF BUYERS             109

5.9.5        INTENSITY OF COMPETITIVE RIVALRY 110

5.10         TARIFF & REGULATORY LANDSCAPE     110

5.10.1      TARIFF DATA (HS CODE 9027)    110

5.10.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             111

5.10.3      REGULATORY FRAMEWORK       114

5.11         PRICING ANALYSIS          117

5.11.1      AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022 —2024               117

5.11.2      AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024        119

5.12         KEY CONFERENCES & EVENTS, 2025–2026              120

5.13         KEY STAKEHOLDERS & BUYING CRITERIA            121

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           121

5.13.2      ROLE OF STAKEHOLDERS IN BUYING PROCESS 122

5.13.3      BUYING CRITERIA           123

5.14         CUSTOMER LANDSCAPE               124

5.14.1      STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES                 124

5.14.2      UNMET NEEDS & WHITE SPACES              126

5.15         INVESTMENT & FUNDING ACTIVITIES  126

5.16         IMPACT OF AI/GENERATIVE AI ON SINGLE-CELL SEQUENCING MARKET 127

5.16.1      AI-USE CASES    128

5.16.2      KEY COMPANIES IMPLEMENTING AI      129

5.16.3      FUTURE OF AI IN SINGLE-CELL SEQUENCING   129

5.17         TRUMP TARIFF IMPACT ON SINGLE-CELL SEQUENCING MARKET               130

5.17.1      INTRODUCTION              130

5.17.2      KEY TARIFF RATES          130

5.17.3      PRICE IMPACT ANALYSIS             131

5.17.4      KEY IMPACT ON VARIOUS REGIONS       132

5.17.4.1  US           132

5.17.4.2  Europe   132

5.17.4.3  Asia Pacific            133

5.17.4.4  Rest of the World 133

5.17.5      END-USE INDUSTRY IMPACT     133

5.17.5.1  Pharmaceutical & biotech companies                133

5.17.5.2  CROs      134

5.17.5.3  Academic & research institutes          134

5.17.5.4  Hospitals & clinical laboratories         134

6               SINGLE-CELL SEQUENCING MARKET, BY OFFERING                 135

6.1           INTRODUCTION              136

6.2           PRODUCTS         136

6.2.1        RECURRING DEMAND FOR CONSUMABLES TO DRIVE MARKET               136

6.3           SERVICES             140

6.3.1        HIGH RELIANCE ON SERVICE PROVIDERS FOR SEQUENCING ACTIVITIES TO PROPEL MARKET                 140

7               SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE     144

7.1           INTRODUCTION              145

7.2           CONSUMABLES 145

7.2.1        PRE-SEQUENCING REAGENTS & KITS     146

7.2.1.1    Ongoing product launches & upgrades to fuel uptake   146

7.2.2        SEQUENCING REAGENTS & KITS               150

7.2.2.1    Ability to provide high-throughput and high-fidelity nucleotide reading to boost demand     150

7.3           INSTRUMENTS 153

7.3.1        PRE-SEQUENCING INSTRUMENTS           154

7.3.1.1    Microfluidic instruments     158

7.3.1.1.1 Increasing demand for reproducible & low-input single-cell workflows to fuel uptake      158

7.3.1.2    Cell sorters             161

7.3.1.2.1 Provision of high-precision isolation of viable cells to boost demand  161

7.3.1.3    PCR instruments  164

7.3.1.3.1 High sensitivity & reproducibility features to fuel uptake                 164

7.3.1.4    LCM instruments 167

7.3.1.4.1 Increasing use across applications requiring spatial resolution to support demand    167

7.3.1.5    Other pre-sequencing instruments   170

7.3.2        SEQUENCING PLATFORMS          173

7.3.2.1    Rising adoption across research applications to drive market                 173

7.4           SOFTWARE         177

7.4.1        SOFTWARE TOOLS          180

7.4.1.1    Rising demand for accurate & scalable processing of sequencing data to support market growth           180

7.4.2        DATA STORAGE & MANAGEMENT SOFTWARE   183

7.4.2.1    Secure handling, archival, and retrieval of large volumes of data to support market growth    183

8               SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW       187

8.1           INTRODUCTION              188

8.2           PRE-SEQUENCING WORKFLOW 188

8.2.1        ABILITY TO ENABLE HIGH-THROUGHPUT WORKFLOW IN CLINICAL & RESEARCH SETTINGS TO DRIVE MARKET                 188

8.3           SEQUENCING WORKFLOW          192

8.3.1        DEMAND FOR MULTI-OMIC SEQUENCING PLATFORMS IN TRANSLATIONAL RESEARCH & ONCOLOGY TO PROPEL MARKET               192

8.4           DATA ANALYSIS & INTERPRETATION WORKFLOW                 195

8.4.1        COMPLEXITY OF SINGLE-CELL DATASETS TO FUEL MARKET               195

9               SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER            199

9.1           INTRODUCTION              200

9.2           ACADEMIC & RESEARCH INSTITUTES    200

9.2.1        RISING FOCUS ON LIFE SCIENCES RESEARCH SUPPORTED BY FAVORABLE GRANTS & FUNDS TO DRIVE MARKET               200

9.3           PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 204

9.3.1        INCREASING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET    204

9.4           HOSPITALS & CLINICAL LABORATORIES               207

9.4.1        RISING INTEGRATION OF ADVANCED SEQUENCING TECHNOLOGIES INTO CLINICAL WORKFLOWS TO BOOST DEMAND             207

9.5           CONTRACT RESEARCH ORGANIZATIONS (CROS)                 211

9.5.1        INCREASING RELIANCE ON OUTSOURCING R&D ACTIVITIES TO SUPPORT MARKET GROWTH     211

10            SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE     215

10.1         INTRODUCTION              216

10.2         PRE-SEQUENCING SERVICES      216

10.2.1      SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES               220

10.2.1.1  Rising demand for high-resolution cell profiling services to fuel market    220

10.2.2      LIBRARY PREPARATION SERVICES           224

10.2.2.1  Adoption of single-cell applications to fuel market         224

10.3         SEQUENCING SERVICES                227

10.3.1      INCREASING DEMAND FOR SCALABLE & APPLICATION-SPECIFIC SEQUENCING OUTPUTS TO DRIVE MARKET   227

10.4         DATA ANALYSIS & BIOINFORMATICS SERVICES 231

10.4.1      INCREASING FOCUS ON CREATION OF END-TO-END ANALYSIS PIPELINES TO SUPPORT MARKET GROWTH  231

11            SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER     235

11.1         INTRODUCTION              236

11.2         ACADEMIC & RESEARCH INSTITUTES    236

11.2.1      EXECUTION OF COMPLEX & LARGE-SCALE CELLULAR STUDIES TO DRIVE MARKET      236

11.3         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 240

11.3.1      INTEGRATION OF HIGH-THROUGHPUT SINGLE-CELL PLATFORMS IN DRUG DISCOVERY ACTIVITIES TO PROPEL MARKET               240

11.4         HOSPITALS & CLINICAL LABORATORIES               243

11.4.1      INCREASING USE ACROSS ONCOLOGY DIAGNOSTICS TO SUPPORT MARKET GROWTH              243

12            SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE     247

12.1         INTRODUCTION              248

12.2         SINGLE-CELL TRANSCRIPTOME SEQUENCING (SCRNA-SEQ)      248

12.2.1      WIDE APPLICATIONS FOR GENE EXPRESSION STUDIES TO DRIVE MARKET         248

12.3         SINGLE-CELL GENOME SEQUENCING (SCDNA-SEQ)                 252

12.3.1      ANALYSIS OF GENOMIC VARIATIONS WITH COMPLEX ADVANCEMENTS TO FUEL MARKET       252

12.4         SINGLE-CELL ATAC SEQUENCING (SCATAC-SEQ)                 255

12.4.1      IDENTIFICATION OF OPEN DNA REGIONS TO SUPPORT MARKET GROWTH          255

12.5         OTHER SINGLE-CELL SEQUENCING TYPES          259

13            SINGLE-CELL SEQUENCING MARKET, BY APPLICATION                 263

13.1         INTRODUCTION              264

13.2         RESEARCH APPLICATIONS          264

13.2.1      BASIC & TRANSLATION RESEARCH          265

13.2.1.1  Cancer research    266

13.2.1.1.1                Growing demand for oncology therapeutics to drive market    266

13.2.1.2  Stem cell & developmental biology    270

13.2.1.2.1                Mapping stem cell heterogeneity and lineage dynamics with high precision to boost demand 270

13.2.1.3  Neurology & brain research                273

13.2.1.3.1                Growing focus on psychiatric & neurodevelopmental disorder research to fuel market         273

13.2.1.4  Microbiology & infectious diseases   277

13.2.1.4.1                Precise profiling of immune responses & pathogen behavior to boost demand   277

13.2.1.5  Organ development & regenerative medicine 280

13.2.1.5.1                Growing focus on precision medicine to fuel uptake                 280

13.2.2      DRUG DISCOVERY & DEVELOPMENT     283

13.2.2.1  Improved target validation and patient stratification using single-cell data to drive market      283

13.3         DIAGNOSTIC & CLINICAL APPLICATIONS            287

13.3.1      RISING UPTAKE IN MOLECULAR DIAGNOSTICS & PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH                 287

14            SINGLE-CELL SEQUENCING MARKET, BY REGION                 291

14.1         INTRODUCTION              292

14.2         NORTH AMERICA             292

14.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 293

14.2.2      US           301

14.2.2.1  Increasing R&D investments & funding to drive market                 301

14.2.3      CANADA               308

14.2.3.1  High prevalence of hemophilia to propel market             308

14.3         EUROPE               315

14.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      315

14.3.2      GERMANY           324

14.3.2.1  Increasing awareness of advanced cell therapies to drive market                 324

14.3.3      UK          330

14.3.3.1  Rising adoption of single-cell analysis products to boost demand                 330

14.3.4      FRANCE                337

14.3.4.1  Favorable government funding investments for genomics to fuel market    337

14.3.5      ITALY    344

14.3.5.1  Growing focus on cell biology research to fuel uptake   344

14.3.6      SPAIN    350

14.3.6.1  Increasing number of biotechnology companies to drive market                 350

14.3.7      REST OF EUROPE             357

14.4         ASIA PACIFIC     364

14.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 365

14.4.2      CHINA  373

14.4.2.1  Increasing incidence of infectious diseases to drive market                 373

14.4.3      JAPAN   379

14.4.3.1  Growing demand for personalized medicine to drive market                 379

14.4.4      INDIA    386

14.4.4.1  Expansion of activities in cell biology and biotech sectors to drive market    386

14.4.5      SOUTH KOREA  393

14.4.5.1  Increasing number of strategic alliances to boost market                 393

14.4.6      AUSTRALIA         400

14.4.6.1  Rising establishment of life science companies to boost demand                 400

14.4.7      REST OF ASIA PACIFIC   407

14.5         LATIN AMERICA                414

14.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 414

14.5.2      BRAZIL 421

14.5.2.1  Focus on advancements in manufacturing infrastructure for biopharmaceuticals to propel market                 421

14.5.3      MEXICO                428

14.5.3.1  Favorable government support for advanced sequencing technologies to drive market               428

14.5.4      REST OF LATIN AMERICA             435

14.6         MIDDLE EAST   442

14.6.1      MACROECONOMIC OUTLOOK IN MIDDLE EAST                 442

14.6.2      GCC COUNTRIES              450

14.6.2.1  Kingdom of Saudi Arabia (KSA)        458

14.6.2.1.1                Increasing healthcare expenditure to drive market                 458

14.6.2.2  United Arab Emirates          464

14.6.2.2.1                Improvements in medical sector to fuel uptake                 464

14.6.2.3  Other GCC Countries          471

14.6.3      REST OF MIDDLE EAST 478

14.7         AFRICA 485

14.7.1      RISING FOCUS ON DRUG DISCOVERY & DEVELOPMENT TO SUPPORT MARKET GROWTH              485

14.7.2      MACROECONOMIC OUTLOOK FOR AFRICA        486

15            COMPETITIVE LANDSCAPE         493

15.1         OVERVIEW          493

15.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025                 493

15.3         REVENUE ANALYSIS, 2022–2024  496

15.4         MARKET SHARE ANALYSIS, 2024                 497

15.5         COMPANY EVALUATION MATRIX: KEY PRODUCT PROVIDERS, 2024              500

15.5.1      STARS   500

15.5.2      EMERGING LEADERS     500

15.5.3      PERVASIVE PLAYERS      500

15.5.4      PARTICIPANTS 501

15.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         502

15.5.5.1  Company footprint               502

15.5.5.2  Region footprint   503

15.5.5.3  Product type footprint         504

15.5.5.4  Workflow footprint               505

15.5.5.5  Application footprint            507

15.6         COMPANY EVALUATION MATRIX: KEY SERVICE PROVIDERS, 2024              508

15.6.1      STARS   508

15.6.2      EMERGING LEADERS     508

15.6.3      PERVASIVE PLAYERS      508

15.6.4      PARTICIPANTS 508

15.6.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         510

15.6.5.1  Company footprint               510

15.6.5.2  Region footprint   511

15.6.5.3  Service footprint   512

15.6.5.4  Application footprint            512

15.7         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        513

15.7.1      PROGRESSIVE COMPANIES         513

15.7.2      RESPONSIVE COMPANIES            513

15.7.3      DYNAMIC COMPANIES  513

15.7.4      STARTING BLOCKS         513

15.7.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 515

15.7.5.1  Detailed list of key startups/SMEs    515

15.7.5.2  Competitive benchmarking of key startups/SMEs          517

15.8         COMPANY VALUATION & FINANCIAL METRICS 518

15.8.1      FINANCIAL METRICS      518

15.8.2      COMPANY VALUATION 518

15.9         BRAND/PRODUCT COMPARISON             519

15.9.1      BRAND/PRODUCT COMPARATIVE ANALYSIS     519

15.10       COMPETITIVE SCENARIO             520

15.10.1   PRODUCT & SERVICE LAUNCHES             520

15.10.2   DEALS  522

16            COMPANY PROFILES      524

16.1         INTRODUCTION              524

16.2         KEY PRODUCT PROVIDERS         524

16.2.1      BECTON, DICKINSON AND COMPANY (BD)         524

16.2.1.1  Business overview 524

16.2.1.2  Products offered   526

16.2.1.3  Recent developments           527

16.2.1.3.1                Product launches  527

16.2.1.3.2                Deals      529

16.2.1.4  MnM view              529

16.2.1.4.1                Key strengths        529

16.2.1.4.2                Strategic choices   530

16.2.1.4.3                Weaknesses & competitive threats     530

16.2.2      THERMO FISHER SCIENTIFIC INC.            531

16.2.2.1  Business overview 531

16.2.2.2  Products offered   532

16.2.2.3  Recent developments           534

16.2.2.3.1                Product launches  534

16.2.2.4  MnM view              534

16.2.2.4.1                Key strengths        534

16.2.2.4.2                Strategic choices   535

16.2.2.4.3                Weaknesses & competitive threats     535

16.2.3      DANAHER CORPORATION           536

16.2.3.1  Business overview 536

16.2.3.2  Products offered   537

16.2.3.3  Recent developments           539

16.2.3.3.1                Product launches  539

16.2.3.3.2                Deals      540

16.2.3.4  MnM view              540

16.2.3.4.1                Key strengths        540

16.2.3.4.2                Strategic choices   540

16.2.3.4.3                Weaknesses & competitive threats     540

16.2.4      10X GENOMICS 541

16.2.4.1  Business overview 541

16.2.4.2  Products offered   542

16.2.4.3  Recent developments           544

16.2.4.3.1                Product launches  544

16.2.4.3.2                Deals      545

16.2.4.4  MnM view              546

16.2.4.4.1                Key strengths        546

16.2.4.4.2                Strategic choices   547

16.2.4.4.3                Weaknesses & competitive threats     547

16.2.5      ILLUMINA, INC. 548

16.2.5.1  Business overview 548

16.2.5.2  Products offered   549

16.2.5.3  Recent developments           551

16.2.5.3.1                Product launches  551

16.2.5.3.2                Deals      552

16.2.5.4  MnM view              552

16.2.5.4.1                Key strengths        552

16.2.5.4.2                Strategic choices   553

16.2.5.4.3                Weaknesses & competitive threats     553

16.2.6      MERCK KGAA    554

16.2.6.1  Business overview 554

16.2.6.2  Products offered   556

16.2.7      QIAGEN N.V.      558

16.2.7.1  Business overview 558

16.2.7.2  Products offered   560

16.2.8      BIO-RAD LABORATORIES, INC.  561

16.2.8.1  Business overview 561

16.2.8.2  Products offered   562

16.2.8.3  Recent developments           564

16.2.8.3.1                Product launches  564

16.2.9      TECAN TRADING AG      565

16.2.9.1  Business overview 565

16.2.9.2  Products offered   566

16.2.9.3  Recent developments           567

16.2.9.3.1                Product launches  567

16.2.9.3.2                Deals      568

16.2.10   CYTEK BIOSCIENCES     569

16.2.10.1                 Business overview 569

16.2.10.2                 Products offered   570

16.2.10.3                 Recent developments           570

16.2.10.3.1             Product launches  570

16.2.10.3.2             Deals      570

16.2.10.3.3             Expansions             571

16.2.11   TAKARA BIO INC.             572

16.2.11.1                 Business overview 572

16.2.11.2                 Products offered   573

16.2.11.3                 Recent developments           575

16.2.11.3.1             Product launches  575

16.2.11.3.2             Deals      575

16.2.12   BIO-TECHNE     576

16.2.12.1                 Business overview 576

16.2.12.2                 Products offered   577

16.2.12.3                 Recent developments           578

16.2.12.3.1             Deals      578

16.2.13   PACBIO 579

16.2.13.1                 Business overview 579

16.2.13.2                 Products offered   580

16.2.13.3                 Recent developments           581

16.2.13.3.1             Product launches  581

16.3         KEY SERVICE PROVIDERS             582

16.3.1      AZENTA US INC.               582

16.3.1.1  Business overview 582

16.3.1.2  Services offered     583

16.3.2      NOVOGENE CO., LTD.   585

16.3.2.1  Business overview 585

16.3.2.2  Services Offered   585

16.3.2.3  Recent developments           586

16.3.2.3.1                Service launches   586

16.3.2.3.2                Expansions             586

16.3.3      IQVIA INC.           588

16.3.3.1  Business overview 588

16.3.3.2  Services offered     589

16.3.4      ALMAC GROUP 590

16.3.4.1  Business overview 590

16.3.4.2  Services offered     590

16.3.5      CEGAT GMBH    591

16.3.5.1  Business overview 591

16.3.5.2  Services offered     591

16.3.6      ACTIVE MOTIF 592

16.3.6.1  Business overview 592

16.3.6.2  Services offered     592

16.4         OTHER PRODUCT PROVIDERS  593

16.4.1      SINGLERON BIOTECHNOLOGIES             593

16.4.2      CELL MICROSYSTEMS   594

16.4.3      NANOCELLECT BIOMEDICAL    595

16.4.4      OXFORD NANOPORE TECHNOLOGIES PLC.        596

16.4.5      REVVITY               597

16.4.6      PARSE BIOSCIENCES      598

16.4.7      ULTIMA GENOMICS        599

16.4.8      MISSION BIO      600

16.5         OTHER SERVICE PROVIDERS      601

16.5.1      SINGLE CELL DISCOVERIES BV  601

16.5.2      ADMERA HEALTH            602

16.5.3      BGI         603

16.5.4      SIGNIOSBIO       604

16.5.5      MACROGEN CO., LTD.   605

16.5.6      LEXOGEN GMBH              606

16.5.7      DISCOVERY LIFE SCIENCES         607

16.5.8      CELLCARTA        608

16.5.9      SINGULOMICS CORPORATION  609

16.5.10   SEQMATIC LLC.                 610

17            APPENDIX           611

17.1         DISCUSSION GUIDE        611

17.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                617

17.3         CUSTOMIZATION OPTIONS        619

17.4         RELATED REPORTS         620

17.5         AUTHOR DETAILS           621

LIST OF TABLES

TABLE 1                SINGLE-CELL SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS       54

TABLE 2                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              68

TABLE 3                SINGLE-CELL SEQUENCING MARKET: RISK ASSESSMENT ANALYSIS 71

TABLE 4                SINGLE-CELL SEQUENCING MARKET: IMPACT ANALYSIS            86

TABLE 5                SINGLE-CELL SEQUENCING MARKET: RAW MATERIAL VENDORS     97

TABLE 6                SINGLE-CELL SEQUENCING MARKET: EMERGING BUSINESS MODELS

& STRATEGIC ADVANTAGE         98

TABLE 7                PATENTS APPLIED & GRANTED, 2014–2024                 102

TABLE 8                INNOVATIONS & PATENT REGISTRATIONS, 2024                 103

TABLE 9                IMPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)          104

TABLE 10              IMPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (TONS)  105

TABLE 11              EXPORT VALUE OF HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (USD THOUSANDS)          106

TABLE 12              EXPORT VOLUME FOR HS CODE 9027-COMPLIANT PRODUCTS FOR

TOP 20 COUNTRIES, 2020–2024 (TONS)  107

TABLE 13              SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 108

TABLE 14              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  111

TABLE 15              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  111

TABLE 16              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  112

TABLE 17              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  113

TABLE 18              SINGLE-CELL SEQUENCING MARKET: REGULATORY GUIDELINES        114

TABLE 19              AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024  117

TABLE 20              AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024     119

TABLE 21              SINGLE-CELL SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2025–2026       120

TABLE 22              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR

SINGLE-CELL SEQUENCING PRODUCTS                122

TABLE 23              BUYING CRITERIA FOR SINGLE-CELL SEQUENCING PRODUCTS, BY END USER               123

TABLE 24              SINGLE-CELL SEQUENCING MARKET: STRATEGIC ANALYSIS

OF GROWTH OPPORTUNITIES  124

TABLE 25              KEY COMPANIES IMPLEMENTING AI IN SINGLE-CELL SEQUENCING MARKET      129

TABLE 26              KEY PRODUCT-RELATED TARIFF: MISCELLANEOUS CHEMICAL PRODUCTS, ELECTRICAL MACHINERY & EQUIPMENT, AND PARTS THEREOF.        131

TABLE 27              SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)     136

TABLE 28              SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION,

2023–2030 (USD MILLION)            137

TABLE 29              NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 30              EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            138

TABLE 31              ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 138

TABLE 32              LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 139

TABLE 33              MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)                 139

TABLE 34              GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 139

TABLE 35              SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            140

TABLE 36              NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 141

TABLE 37              EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            141

TABLE 38              ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 142

TABLE 39              LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 142

TABLE 40              MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            142

TABLE 41              GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 143

TABLE 42             SINGLE-CELL SEQUENCING PRODUCT MARKET, BY TYPE,

2023–2030 (USD MILLION)            145

TABLE 43              SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            146

TABLE 44              PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION,

2023–2030 (USD MILLION)            147

TABLE 45              NORTH AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       147

TABLE 46              EUROPE: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 47              ASIA PACIFIC: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 48              LATIN AMERICA: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               149

TABLE 49              MIDDLE EAST: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY REGION, 2023–2030 (USD MILLION)   149

TABLE 50              GCC COUNTRIES: PRE-SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            149

TABLE 51              SEQUENCING REAGENTS & KITS CONSUMABLES MARKET, BY REGION,

2023–2030 (USD MILLION)            150

TABLE 52              NORTH AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 53              EUROPE: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 54              ASIA PACIFIC: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               152

TABLE 55              LATIN AMERICA: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               152

TABLE 56              MIDDLE EAST: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY REGION, 2023–2030 (USD MILLION)   153

TABLE 57              GCC COUNTRIES: SEQUENCING REAGENTS & KITS CONSUMABLES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               153

TABLE 58              SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            154

TABLE 59              PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            154

TABLE 60              NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 61              EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 62              ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 63              LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 64              MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            157

TABLE 65              GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            157

TABLE 66              PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                157

TABLE 67              MICROFLUIDIC INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)          158

TABLE 68              NORTH AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            158

TABLE 69              EUROPE: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            159

TABLE 70              ASIA PACIFIC: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          159

TABLE 71              LATIN AMERICA: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            160

TABLE 72              MIDDLE EAST: MICROFLUIDIC INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            160

TABLE 73              GCC COUNTRIES: MICROFLUIDIC INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            160

TABLE 74              CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 161

TABLE 75              NORTH AMERICA: CELL SORTERS MARKET, 2023–2030 (USD MILLION)            161

TABLE 76             EUROPE: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            162

TABLE 77              ASIA PACIFIC: CELL SORTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     162

TABLE 78              LATIN AMERICA: CELL SORTERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 79              MIDDLE EAST: CELL SORTERS MARKET, BY REGION, 2023–2030 (USD MILLION)          163

TABLE 80              GCC COUNTRIES: CELL SORTERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            163

TABLE 81              PCR INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)       164

TABLE 82              NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            164

TABLE 83              EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     165

TABLE 84              ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            165

TABLE 85              LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            166

TABLE 86              MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            166

TABLE 87              GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            166

TABLE 88              LCM INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)       167

TABLE 89             NORTH AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            167

TABLE 90              EUROPE: LCM INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     168

TABLE 91              ASIA PACIFIC: LCM INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 92              LATIN AMERICA: LCM INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            169

TABLE 93              MIDDLE EAST: LCM INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            169

TABLE 94              GCC COUNTRIES: LCM INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            169

TABLE 95              OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            170

TABLE 96              NORTH AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            170

TABLE 97              EUROPE: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            171

TABLE 98              ASIA PACIFIC: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            171

TABLE 99              LATIN AMERICA: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            172

TABLE 100            MIDDLE EAST: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)                 172

TABLE 101            GCC COUNTRIES: OTHER PRE-SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            172

TABLE 102            SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS)            173

TABLE 103            SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            174

TABLE 104            NORTH AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               174

TABLE 105            EUROPE: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            175

TABLE 106            ASIA PACIFIC: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            175

TABLE 107            LATIN AMERICA: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            176

TABLE 108            MIDDLE EAST: SEQUENCING PLATFORMS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)                 176

TABLE 109            GCC COUNTRIES: SEQUENCING PLATFORMS INSTRUMENTS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               176

TABLE 110            SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION,

2023–2030 (USD MILLION)            177

TABLE 111            NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 177

TABLE 112            EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            178

TABLE 113            ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 178

TABLE 114            LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 179

TABLE 115            MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)                 179

TABLE 116            GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 179

TABLE 117            SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            180

TABLE 118            SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET, BY REGION,

2023–2030 (USD MILLION)            180

TABLE 119            NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 120            EUROPE: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 121            ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               182

TABLE 122            LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               182

TABLE 123            MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET,

BY REGION, 2023–2030 (USD MILLION)   182

TABLE 124            GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE TOOLS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               183

TABLE 125            SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 184

TABLE 126            NORTH AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     184

TABLE 127            EUROPE: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, 2023–2030 (USD MILLION) 185

TABLE 128            ASIA PACIFIC: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     185

TABLE 129            LATIN AMERICA: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     186

TABLE 130            MIDDLE EAST: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)          186

TABLE 131            GCC COUNTRIES: SINGLE-CELL SEQUENCING DATA STORAGE & MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     186

TABLE 132          SINGLE-CELL SEQUENCING PRODUCT MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            188

TABLE 133            PRE-SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          189

TABLE 134            NORTH AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 135          EUROPE: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 136            ASIA PACIFIC: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            190

TABLE 137            LATIN AMERICA: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            191

TABLE 138            MIDDLE EAST: PRE-SEQUENCING PRODUCT MARKET, BY REGION,

2023–2030 (USD MILLION)            191

TABLE 139            GCC COUNTRIES: PRE-SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            191

TABLE 140            SEQUENCING PRODUCT MARKET, BY REGION, 2023–2030 (USD MILLION)            192

TABLE 141            NORTH AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            193

TABLE 142            EUROPE: SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            193

TABLE 143          ASIA PACIFIC: SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            194

TABLE 144            LATIN AMERICA: SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            194

TABLE 145            MIDDLE EAST: SEQUENCING PRODUCT MARKET, BY REGION,

2023–2030 (USD MILLION)            195

TABLE 146            GCC COUNTRIES: SEQUENCING PRODUCT MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            195

TABLE 147            DATA ANALYSIS & INTERPRETATION PRODUCT MARKET, BY REGION,

2023–2030 (USD MILLION)            196

TABLE 148            NORTH AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               196

TABLE 149            EUROPE: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 150            ASIA PACIFIC: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               197

TABLE 151            LATIN AMERICA: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               198

TABLE 152            MIDDLE EAST: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET,

BY REGION, 2023–2030 (USD MILLION)   198

TABLE 153            GCC COUNTRIES: DATA ANALYSIS & INTERPRETATION PRODUCT MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               198

TABLE 154          SINGLE-CELL SEQUENCING PRODUCT MARKET, BY END USER,

2023–2030 (USD MILLION)            200

TABLE 155            SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC &

RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)                 201

TABLE 156            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               201

TABLE 157            EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               202

TABLE 158            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               202

TABLE 159            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 160            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)   203

TABLE 161            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 162            SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          204

TABLE 163            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            205

TABLE 164            EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)            205

TABLE 165            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            206

TABLE 166            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            206

TABLE 167            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,

2023–2030 (USD MILLION)            206

TABLE 168            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            207

TABLE 169            SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)       208

TABLE 170            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 208

TABLE 171            EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 209

TABLE 172            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 209

TABLE 173            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 210

TABLE 174            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 210

TABLE 175            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 210

TABLE 176            SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)            211

TABLE 177            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 212

TABLE 178            EUROPE: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 212

TABLE 179            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 213

TABLE 180            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 213

TABLE 181            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023–2030 (USD MILLION)                 213

TABLE 182            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCT MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 214

TABLE 183            SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            216

TABLE 184            PRE-SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          217

TABLE 185            NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            217

TABLE 186            EUROPE: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            218

TABLE 187            ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            218

TABLE 188            LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            219

TABLE 189            MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            219

TABLE 190            GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            219

TABLE 191            PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            220

TABLE 192            SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            221

TABLE 193            NORTH AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)           221

TABLE 194            EUROPE: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     222

TABLE 195            ASIA PACIFIC: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     222

TABLE 196            LATIN AMERICA: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)           223

TABLE 197            MIDDLE EAST: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          223

TABLE 198            GCC COUNTRIES: SAMPLE PREPARATION, SINGLE-CELL ISOLATION, AND ENRICHMENT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)           223

TABLE 199            LIBRARY PREPARATION SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            224

TABLE 200            NORTH AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 225

TABLE 201            EUROPE: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            225

TABLE 202            ASIA PACIFIC: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            226

TABLE 203            LATIN AMERICA: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            226

TABLE 204            MIDDLE EAST: LIBRARY PREPARATION SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            227

TABLE 205            GCC COUNTRIES: LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 227

TABLE 206            SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)            228

TABLE 207            NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            228

TABLE 208            EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            229

TABLE 209            ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            229

TABLE 210            LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            230

TABLE 211            MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            230

TABLE 212            GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            230

TABLE 213            DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            231

TABLE 214            NORTH AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               232

TABLE 215            EUROPE: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 232

TABLE 216            ASIA PACIFIC: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 217            LATIN AMERICA: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 218            MIDDLE EAST: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   234

TABLE 219            GCC COUNTRIES: DATA ANALYSIS & BIOINFORMATICS SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 220            SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)          236

TABLE 221            SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)       237

TABLE 222            NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               237

TABLE 223            EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)     238

TABLE 224            ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               238

TABLE 225            LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 226            MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)   239

TABLE 227            GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 228            SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          240

TABLE 229            NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            241

TABLE 230            EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   241

TABLE 231            ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            242

TABLE 232            LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            242

TABLE 233            MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,

2023–2030 (USD MILLION)            242

TABLE 234            GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2023–2030 (USD MILLION)            243

TABLE 235            SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION)       244

TABLE 236            NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 244

TABLE 237            EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)     245

TABLE 238            ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 245

TABLE 239            LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 246

TABLE 240            MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 246

TABLE 241            GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)                 246

TABLE 242            SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            248

TABLE 243            SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY REGION,

2023–2030 (USD MILLION)            249

TABLE 244            NORTH AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               249

TABLE 245            EUROPE: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 250

TABLE 246            ASIA PACIFIC: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               250

TABLE 247            LATIN AMERICA: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               251

TABLE 248            MIDDLE EAST: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET,

BY REGION, 2023–2030 (USD MILLION)   251

TABLE 249            GCC COUNTRIES: SINGLE-CELL TRANSCRIPTOME SEQUENCING MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               251

TABLE 250            SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION,

2023–2030 (USD MILLION)            252

TABLE 251            NORTH AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               253

TABLE 252            EUROPE: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            253

TABLE 253            ASIA PACIFIC: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            254

TABLE 254            LATIN AMERICA: SINGLE-CELL GENOME SEQUENCING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 254

TABLE 255            MIDDLE EAST: SINGLE-CELL GENOME SEQUENCING MARKET, BY REGION,

2023–2030 (USD MILLION)            255

TABLE 256            GCC COUNTRIES: SINGLE-CELL GENOME SEQUENCING MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               255

TABLE 257            SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION,

2023–2030 (USD MILLION)            256

TABLE 258            NORTH AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            256

TABLE 259            EUROPE: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            257

TABLE 260            ASIA PACIFIC: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            257

TABLE 261            LATIN AMERICA: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            258

TABLE 262            MIDDLE EAST: SINGLE-CELL ATAC SEQUENCING MARKET, BY REGION,

2023–2030 (USD MILLION)            258

TABLE 263            GCC COUNTRIES: SINGLE-CELL ATAC SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            258

TABLE 264            OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION,

2023–2030 (USD MILLION)            259

TABLE 265            NORTH AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               260

TABLE 266            EUROPE: OTHER SINGLE-CELL SEQUENCING TYPES MARKET,

2023–2030 (USD MILLION)            260

TABLE 267            ASIA PACIFIC: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            261

TABLE 268            LATIN AMERICA: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            261

TABLE 269            MIDDLE EAST: OTHER SINGLE-CELL SEQUENCING TYPES MARKET, BY REGION, 2023–2030 (USD MILLION)            262

TABLE 270            GCC COUNTRIES: OTHER SINGLE-CELL SEQUENCING TYPES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               262

TABLE 271            SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              264

TABLE 272            SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 265

TABLE 273            SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATIONAL RESEARCH,

BY TYPE, 2023–2030 (USD MILLION)         266

TABLE 274            SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY REGION,

2023–2030 (USD MILLION)            267

TABLE 275            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 267

TABLE 276            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               268

TABLE 277            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               268

TABLE 278            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH,

BY COUNTRY, 2023–2030 (USD MILLION)               269

TABLE 279            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH,

BY REGION, 2023–2030 (USD MILLION)   269

TABLE 280            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR CANCER RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 269

TABLE 281            SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION) 270

TABLE 282            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)     271

TABLE 283            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)            271

TABLE 284            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)     272

TABLE 285            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)     272

TABLE 286            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2030 (USD MILLION)          273

TABLE 287            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR STEM CELL & DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)     273

TABLE 288            SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH,

BY REGION, 2023–2030 (USD MILLION)   274

TABLE 289            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)            274

TABLE 290            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY & BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 275

TABLE 291            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY &

BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 275

TABLE 292            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY &

BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 276

TABLE 293            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY &

BRAIN RESEARCH, BY REGION, 2023–2030 (USD MILLION)                 276

TABLE 294            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR NEUROLOGY &

BRAIN RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)                 276

TABLE 295            SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)       277

TABLE 296            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)     278

TABLE 297            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)            278

TABLE 298            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)     279

TABLE 299            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)     279

TABLE 300            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION)          279

TABLE 301            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR MICROBIOLOGY & INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)     280

TABLE 302            SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)          280

TABLE 303            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)       281

TABLE 304            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)     281

TABLE 305            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)       282

TABLE 306            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)       282

TABLE 307            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)            282

TABLE 308            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR ORGAN DEVELOPMENT & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)       283

TABLE 309            SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT,

BY REGION, 2023–2030 (USD MILLION)   284

TABLE 310            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)     284

TABLE 311            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)       285

TABLE 312            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)     285

TABLE 313            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)     286

TABLE 314            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)            286

TABLE 315            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)     286

TABLE 316            SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 287

TABLE 317            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     288

TABLE 318            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)            288

TABLE 319            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     289

TABLE 320            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     289

TABLE 321            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)          289

TABLE 322            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR DIAGNOSTIC & CLINICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)     290

TABLE 323            SINGLE-CELL SEQUENCING MARKET, BY REGION, 2023–2030 (USD MILLION)          292

TABLE 324            NORTH AMERICA: MACROECONOMIC INDICATORS      293

TABLE 325            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            294

TABLE 326            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 295

TABLE 327            NORTH AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         295

TABLE 328            NORTH AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         295

TABLE 329            NORTH AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            296

TABLE 330            NORTH AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)                 296

TABLE 331            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           297

TABLE 332            NORTH AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               297

TABLE 333            NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         298

TABLE 334            NORTH AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            298

TABLE 335            NORTH AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               299

TABLE 336            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)                 299

TABLE 337            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            300

TABLE 338            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 300

TABLE 339            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        301

TABLE 340            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            301

TABLE 341            US: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            302

TABLE 342            US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            303

TABLE 343            US: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            303

TABLE 344            US: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            303

TABLE 345            US: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 346            US: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            304

TABLE 347            US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            304

TABLE 348            US: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            305

TABLE 349            US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            305

TABLE 350            US: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                306

TABLE 351            US: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            306

TABLE 352            US: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            307

TABLE 353            US: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            307

TABLE 354            US: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 307

TABLE 355            US: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            308

TABLE 356            CANADA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            309

TABLE 357            CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            309

TABLE 358            CANADA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            309

TABLE 359            CANADA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 360            CANADA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 361            CANADA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 362            CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            311

TABLE 363            CANADA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            311

TABLE 364            CANADA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            312

TABLE 365          CANADA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            312

TABLE 366            CANADA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            313

TABLE 367            CANADA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            313

TABLE 368            CANADA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            314

TABLE 369            CANADA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         314

TABLE 370            CANADA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                315

TABLE 371            EUROPE: MACROECONOMIC INDICATORS                 316

TABLE 372            EUROPE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            317

TABLE 373            EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2

023–2030 (USD MILLION)               317

TABLE 374            EUROPE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            317

TABLE 375            EUROPE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 376            EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 377            EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            318

TABLE 378            EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            319

TABLE 379            EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            319

TABLE 380            EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            320

TABLE 381            EUROPE: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            320

TABLE 382            EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            321

TABLE 383            EUROPE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            321

TABLE 384            EUROPE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            322

TABLE 385            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         322

TABLE 386            EUROPE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                323

TABLE 387            EUROPE: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            323

TABLE 388            GERMANY: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            324

TABLE 389            GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            324

TABLE 390            GERMANY: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            325

TABLE 391            GERMANY: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            325

TABLE 392            GERMANY: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            325

TABLE 393            GERMANY: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            326

TABLE 394            GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 326

TABLE 395            GERMANY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            327

TABLE 396            GERMANY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            327

TABLE 397            GERMANY: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            328

TABLE 398            GERMANY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            328

TABLE 399            GERMANY: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            329

TABLE 400            GERMANY: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            329

TABLE 401            GERMANY: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         329

TABLE 402            GERMANY: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        330

TABLE 403            UK: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            331

TABLE 404            UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            331

TABLE 405            UK: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            331

TABLE 406            UK: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            332

TABLE 407            UK: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            332

TABLE 408            UK: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            332

TABLE 409            UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            333

TABLE 410            UK: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            333

TABLE 411            UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            334

TABLE 412            UK: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)                334

TABLE 413            UK: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            335

TABLE 414            UK: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            335

TABLE 415            UK: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            336

TABLE 416            UK: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         336

TABLE 417            UK: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)            337

TABLE 418            FRANCE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            338

TABLE 419            FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            338

TABLE 420            FRANCE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            338

TABLE 421            FRANCE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 422            FRANCE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            339

TABLE 423            FRANCE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)          339

TABLE 424            FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            340

TABLE 425            FRANCE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            340

TABLE 426            FRANCE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            341

TABLE 427            FRANCE: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            341

TABLE 428            FRANCE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            342

TABLE 429            FRANCE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            342

TABLE 430            FRANCE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            343

TABLE 431            FRANCE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         343

TABLE 432            FRANCE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                344

TABLE 433            ITALY: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            345

TABLE 434            ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 435            ITALY: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            345

TABLE 436            ITALY: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            346

TABLE 437            ITALY: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            346

TABLE 438            ITALY: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            346

TABLE 439            ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            347

TABLE 440            ITALY: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            347

TABLE 441            ITALY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            348

TABLE 442            ITALY: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)         348

TABLE 443            ITALY: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            349

TABLE 444            ITALY: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            349

TABLE 445            ITALY: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            349

TABLE 446            ITALY: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         350

TABLE 447            ITALY: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                350

TABLE 448            SPAIN: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            351

TABLE 449            SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            351

TABLE 450            SPAIN: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 451            SPAIN: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 452            SPAIN: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            352

TABLE 453            SPAIN: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            353

TABLE 454            SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            353

TABLE 455            SPAIN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            354

TABLE 456            SPAIN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            354

TABLE 457            SPAIN: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            355

TABLE 458            SPAIN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            355

TABLE 459            SPAIN: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            356

TABLE 460            SPAIN: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            356

TABLE 461            SPAIN: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         356

TABLE 462            SPAIN: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                357

TABLE 463            REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            357

TABLE 464            REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 358

TABLE 465            REST OF EUROPE: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 358

TABLE 466            REST OF EUROPE: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 358

TABLE 467            REST OF EUROPE: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            359

TABLE 468            REST OF EUROPE: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)                 359

TABLE 469            REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           360

TABLE 470            REST OF EUROPE: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               360

TABLE 471            REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            361

TABLE 472            REST OF EUROPE: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            361

TABLE 473            REST OF EUROPE: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               362

TABLE 474            REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)                 362

TABLE 475            REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            363

TABLE 476            REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 363

TABLE 477            REST OF EUROPE: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        364

TABLE 478            ASIA PACIFIC: MACROECONOMIC INDICATORS                 365

TABLE 479            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            366

TABLE 480            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            367

TABLE 481            ASIA PACIFIC: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 367

TABLE 482            ASIA PACIFIC: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 367

TABLE 483            ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 484            ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            368

TABLE 485            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 368

TABLE 486            ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 369

TABLE 487            ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            369

TABLE 488            SIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            370

TABLE 489            ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 370

TABLE 490            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            371

TABLE 491            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            371

TABLE 492            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 371

TABLE 493            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        372

TABLE 494            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            372

TABLE 495            CHINA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            373

TABLE 496            CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            373

TABLE 497            CHINA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 498            CHINA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 499            CHINA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            374

TABLE 500            CHINA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            375

TABLE 501            CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            375

TABLE 502            CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            376

TABLE 503            CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            376

TABLE 504            CHINA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            377

TABLE 505            CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            377

TABLE 506            CHINA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            378

TABLE 507            CHINA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            378

TABLE 508            CHINA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         378

TABLE 509            CHINA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                379

TABLE 510            JAPAN: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            380

TABLE 511            JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            380

TABLE 512            JAPAN: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            380

TABLE 513            JAPAN: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 514            JAPAN: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 515            JAPAN: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            381

TABLE 516            JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            382

TABLE 517            JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            382

TABLE 518            JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 519            JAPAN: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            383

TABLE 520            JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            384

TABLE 521            JAPAN: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)          384

TABLE 522            JAPAN: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            385

TABLE 523            JAPAN: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         385

TABLE 524            JAPAN: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                386

TABLE 525            INDIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            387

TABLE 526            INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            387

TABLE 527            INDIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            387

TABLE 528            INDIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 529            INDIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 530            INDIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            388

TABLE 531            INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            389

TABLE 532            INDIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            389

TABLE 533            INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            390

TABLE 534            INDIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            390

TABLE 535            INDIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            391

TABLE 536            INDIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            391

TABLE 537            INDIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            392

TABLE 538            INDIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         392

TABLE 539            INDIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION

RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                 393

TABLE 540            SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            394

TABLE 541            SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            394

TABLE 542            SOUTH KOREA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 394

TABLE 543            SOUTH KOREA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 395

TABLE 544            SOUTH KOREA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            395

TABLE 545            SOUTH KOREA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            395

TABLE 546            SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 396

TABLE 547            SOUTH KOREA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 396

TABLE 548            SOUTH KOREA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            397

TABLE 549            SOUTH KOREA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            397

TABLE 550            SOUTH KOREA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               398

TABLE 551            SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)                 398

TABLE 552            SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            399

TABLE 553            SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 399

TABLE 554            SOUTH KOREA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        400

TABLE 555            AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            401

TABLE 556            AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            401

TABLE 557            AUSTRALIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            401

TABLE 558            AUSTRALIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 559            AUSTRALIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 560            AUSTRALIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            402

TABLE 561            AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 403

TABLE 562            AUSTRALIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 403

TABLE 563            AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            404

TABLE 564            AUSTRALIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            404

TABLE 565            AUSTRALIA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            405

TABLE 566            AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            405

TABLE 567            AUSTRALIA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            406

TABLE 568            AUSTRALIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 406

TABLE 569            AUSTRALIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        407

TABLE 570            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            408

TABLE 571            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 572            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         408

TABLE 573            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         409

TABLE 574            REST OF ASIA PACIFIC: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 409

TABLE 575            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SOFTWARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         409

TABLE 576            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           410

TABLE 577            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               410

TABLE 578            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         411

TABLE 579            REST OF ASIA PACIFIC: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            411

TABLE 580            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               412

TABLE 581            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)            412

TABLE 582            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            413

TABLE 583            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                413

TABLE 584            REST OF ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        414

TABLE 585            LATIN AMERICA: MACROECONOMIC INDICATORS      415

TABLE 586            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            415

TABLE 587            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            415

TABLE 588            LATIN AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 416

TABLE 589            LATIN AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 416

TABLE 590            LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            416

TABLE 591            LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            417

TABLE 592            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 417

TABLE 593            LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 418

TABLE 594            LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            418

TABLE 595            LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            419

TABLE 596            LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 419

TABLE 597            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)                 420

TABLE 598            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            420

TABLE 599            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 420

TABLE 600            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        421

TABLE 601            LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            421

TABLE 602            BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            422

TABLE 603            BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            422

TABLE 604            BRAZIL: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            423

TABLE 605            BRAZIL: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            423

TABLE 606            BRAZIL: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            423

TABLE 607            BRAZIL: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            424

TABLE 608            BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            424

TABLE 609            BRAZIL: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            425

TABLE 610            BRAZIL: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            425

TABLE 611            BRAZIL: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            426

TABLE 612            BRAZIL: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            426

TABLE 613            BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            427

TABLE 614            BRAZIL: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            427

TABLE 615            BRAZIL: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         427

TABLE 616            BRAZIL: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                428

TABLE 617            MEXICO: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            429

TABLE 618            MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            429

TABLE 619            MEXICO: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            429

TABLE 620            MEXICO: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            430

TABLE 621            MEXICO: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            430

TABLE 622            MEXICO: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            430

TABLE 623            MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            431

TABLE 624            MEXICO: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            431

TABLE 625            MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)          432

TABLE 626            MEXICO: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            432

TABLE 627            MEXICO: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            433

TABLE 628            MEXICO: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            433

TABLE 629            MEXICO: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            434

TABLE 630            MEXICO: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         434

TABLE 631            MEXICO: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                435

TABLE 632            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            436

TABLE 633            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         436

TABLE 634            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         436

TABLE 635            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         437

TABLE 636            REST OF LATIN AMERICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 437

TABLE 637            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         437

TABLE 638            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           438

TABLE 639            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               438

TABLE 640            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)       439

TABLE 641            REST OF LATIN AMERICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            439

TABLE 642            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               440

TABLE 643            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)            440

TABLE 644            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            441

TABLE 645            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                441

TABLE 646            REST OF LATIN AMERICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        442

TABLE 647            MIDDLE EAST: MACROECONOMIC INDICATORS                 443

TABLE 648            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            443

TABLE 649            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            444

TABLE 650            MIDDLE EAST: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 444

TABLE 651            MIDDLE EAST: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 444

TABLE 652            MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            445

TABLE 653            MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            445

TABLE 654            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 446

TABLE 655            MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 446

TABLE 656            MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            447

TABLE 657            MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            447

TABLE 658            MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 448

TABLE 659            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            448

TABLE 660            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            449

TABLE 661            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 449

TABLE 662            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        450

TABLE 663            MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY REGION,

2023–2030 (USD MILLION)            450

TABLE 664            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            451

TABLE 665            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 451

TABLE 666            GCC COUNTRIES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 451

TABLE 667            GCC COUNTRIES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 452

TABLE 668            GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            452

TABLE 669            GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)                 452

TABLE 670            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2023–2030 (USD MILLION)                 453

TABLE 671            GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)                 453

TABLE 672            GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            454

TABLE 673            GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            454

TABLE 674            GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 455

TABLE 675            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)                 455

TABLE 676            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            456

TABLE 677            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 456

TABLE 678            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        457

TABLE 679            GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            457

TABLE 680            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            458

TABLE 681            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         458

TABLE 682            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 459

TABLE 683            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            459

TABLE 684            KINGDOM OF SAUDI ARABIA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            459

TABLE 685            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SOFTWARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)       460

TABLE 686            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           460

TABLE 687            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               461

TABLE 688            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         461

TABLE 689            KINGDOM OF SAUDI ARABIA: PRE-SEQUENCING SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)            462

TABLE 690            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               462

TABLE 691            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET,

BY SEQUENCING TYPE, 2023–2030 (USD MILLION)            463

TABLE 692            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       463

TABLE 693            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                463

TABLE 694            KINGDOM OF SAUDI ARABIA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        464

TABLE 695            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            465

TABLE 696            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         465

TABLE 697            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         465

TABLE 698            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         466

TABLE 699            UNITED ARAB EMIRATES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 466

TABLE 700            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SOFTWARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         466

TABLE 701            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           467

TABLE 702            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               467

TABLE 703            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         468

TABLE 704            UNITED ARAB EMIRATES: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            468

TABLE 705            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               469

TABLE 706            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)            469

TABLE 707            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            470

TABLE 708            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                470

TABLE 709            UNITED ARAB EMIRATES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        471

TABLE 710            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            471

TABLE 711            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         472

TABLE 712            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         472

TABLE 713            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         472

TABLE 714            OTHER GCC COUNTRIES: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 473

TABLE 715            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SOFTWARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         473

TABLE 716            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           474

TABLE 717            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               474

TABLE 718            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         475

TABLE 719            OTHER GCC COUNTRIES: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            475

TABLE 720            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               476

TABLE 721            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)            476

TABLE 722            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            477

TABLE 723            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                477

TABLE 724            OTHER GCC COUNTRIES: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        478

TABLE 725            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY OFFERING, 2023–2030 (USD MILLION)            479

TABLE 726            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         479

TABLE 727            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING CONSUMABLES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         479

TABLE 728            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         480

TABLE 729            REST OF MIDDLE EAST: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                 480

TABLE 730            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SOFTWARE MARKET,

BY TYPE, 2023–2030 (USD MILLION)         480

TABLE 731            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY WORKFLOW, 2023–2030 (USD MILLION)           481

TABLE 732            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING PRODUCTS MARKET,

BY END USER, 2023–2030 (USD MILLION)               481

TABLE 733            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         482

TABLE 734            REST OF MIDDLE EAST: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            482

TABLE 735            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               483

TABLE 736            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE, 2023–2030 (USD MILLION)            483

TABLE 737            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            484

TABLE 738            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                484

TABLE 739            REST OF MIDDLE EAST: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)        485

TABLE 740            MACROECONOMIC OUTLOOK FOR AFRICA                 486

TABLE 741            AFRICA: SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2023–2030 (USD MILLION)            486

TABLE 742            AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            487

TABLE 743            AFRICA: SINGLE-CELL SEQUENCING CONSUMABLES MARKET, BY TYPE,

2023–2030 (USD MILLION)            487

TABLE 744            AFRICA: SINGLE-CELL SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            487

TABLE 745            AFRICA: PRE-SEQUENCING INSTRUMENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            488

TABLE 746            AFRICA: SINGLE-CELL SEQUENCING SOFTWARE MARKET, BY TYPE,

2023–2030 (USD MILLION)            488

TABLE 747            AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW,

2023–2030 (USD MILLION)            488

TABLE 748            AFRICA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2023–2030 (USD MILLION)            489

TABLE 749            AFRICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            489

TABLE 750            AFRICA: PRE-SEQUENCING SERVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            490

TABLE 751            AFRICA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            490

TABLE 752            AFRICA: SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2023–2030 (USD MILLION)            491

TABLE 753            AFRICA: SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            491

TABLE 754            AFRICA: SINGLE-CELL SEQUENCING MARKET FOR RESEARCH APPLICATIONS,

BY TYPE, 2023–2030 (USD MILLION)         491

TABLE 755            AFRICA: SINGLE-CELL SEQUENCING MARKET FOR BASIC & TRANSLATION RESEARCH APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)                492

TABLE 756            SINGLE-CELL SEQUENCING MARKET: OVERVIEW OF STRATEGIES ADOPTED

BY KEY PLAYERS, 2021–2025          493

TABLE 757            SINGLE-CELL SEQUENCING MARKET: DEGREE OF COMPETITION           498

TABLE 758            SINGLE-CELL SEQUENCING PRODUCT MARKET: REGION FOOTPRINT 503

TABLE 759            SINGLE-CELL SEQUENCING PRODUCT MARKET: PRODUCT TYPE FOOTPRINT 504

TABLE 760            SINGLE-CELL SEQUENCING PRODUCT MARKET: WORKFLOW FOOTPRINT         505

TABLE 761            SINGLE-CELL SEQUENCING PRODUCT MARKET: APPLICATION FOOTPRINT     507

TABLE 762            SINGLE-CELL SEQUENCING SERVICE MARKET: REGION FOOTPRINT     511

TABLE 763            SINGLE-CELL SEQUENCING SERVICE MARKET: SERVICE TYPE FOOTPRINT         512

TABLE 764            SINGLE-CELL SEQUENCING SERVICE MARKET: APPLICATION FOOTPRINT         512

TABLE 765            SINGLE-CELL SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES             515

TABLE 766            SINGLE-CELL SEQUENCING MARKET: COMPETITIVE BENCHMARKING OF

KEY STARTUPS/SMES  517

TABLE 767            SINGLE-CELL SEQUENCING MARKET: PRODUCT & SERVICE LAUNCHES,

JANUARY 2021–JULY 2025               520

TABLE 768            SINGLE-CELL SEQUENCING MARKET: DEALS, JANUARY 2021–JULY 2025               522

TABLE 769            BD: COMPANY OVERVIEW           525

TABLE 770            BD: PRODUCTS OFFERED            526

TABLE 771            BD: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025        527

TABLE 772            BD: DEALS, JANUARY 2021–JULY 2025      529

TABLE 773            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          531

TABLE 774            THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED             532

TABLE 775            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES,

JANUARY 2021–JULY 2025               534

TABLE 776            DANAHER CORPORATION: COMPANY OVERVIEW          536

TABLE 777            DANAHER CORPORATION: PRODUCTS OFFERED             537

TABLE 778            DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025     539

TABLE 779            DANAHER CORPORATION: DEALS, JANUARY 2021–JULY 2025  540

TABLE 780            10X GENOMICS: COMPANY OVERVIEW  541

TABLE 781            10X GENOMICS: PRODUCTS OFFERED   542

TABLE 782            10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               544

TABLE 783            10X GENOMICS: DEALS, JANUARY 2021–APRIL 2025        545

TABLE 784            ILLUMINA, INC.: COMPANY OVERVIEW 548

TABLE 785            ILLUMINA, INC.: PRODUCTS OFFERED  549

TABLE 786            ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               551

TABLE 787            ILLUMINA, INC.: DEALS, JANUARY 2021–APRIL 2025        552

TABLE 788            MERCK KGAA: COMPANY OVERVIEW     554

TABLE 789            MERCK KGAA: PRODUCTS OFFERED      556

TABLE 790            QIAGEN N.V.: COMPANY OVERVIEW       558

TABLE 791            QIAGEN N.V.: PRODUCTS OFFERED        560

TABLE 792            BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW          561

TABLE 793            BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED             562

TABLE 794            BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025     564

TABLE 795            TECAN TRADING AG: COMPANY OVERVIEW                 565

TABLE 796            TECAN TRADING AG: PRODUCTS OFFERED                 566

TABLE 797            TECAN TRADING AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               567

TABLE 798            TECAN TRADING AG: DEALS, JANUARY 2021–JULY 2025             568

TABLE 799            CYTEK BIOSCIENCES: COMPANY OVERVIEW                 569

TABLE 800            CYTEK BIOSCIENCES: PRODUCTS OFFERED                 570

TABLE 801            CYTEK BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               570

TABLE 802            CYTEK BIOSCIENCES: DEALS, JANUARY 2021–JULY 2025             570

TABLE 803            CYTEK BIOSCIENCES: EXPANSIONS, JANUARY 2021–JULY 2025  571

TABLE 804            TAKARA BIO INC.: COMPANY OVERVIEW                 572

TABLE 805            TAKARA BIO INC.: PRODUCTS OFFERED                 573

TABLE 806            TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025               575

TABLE 807            TAKARA BIO INC.: DEALS, JANUARY 2021–JULY 2025        575

TABLE 808            BIO-TECHNE: COMPANY OVERVIEW      576

TABLE 809            BIO-TECHNE: PRODUCTS OFFERED       577

TABLE 810            BIO-TECHNE: DEALS, JANUARY 2021–JULY 2025                 578

TABLE 811            PACBIO: COMPANY OVERVIEW 579

TABLE 812            PACBIO: PRODUCTS OFFERED  580

TABLE 813            PACBIO: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025             581

TABLE 814            AZENTA US INC.: COMPANY OVERVIEW                 582

TABLE 815            AZENTA US INC.: SERVICES OFFERED    583

TABLE 816            NOVOGENE CO., LTD.: COMPANY OVERVIEW                 585

TABLE 817            NOVOGENE CO., LTD.: SERVICES OFFERED                 585

TABLE 818            NOVOGENE CO., LTD.: SERVICE LAUNCHES, JANUARY 2021–JULY 2025               586

TABLE 819            NOVOGENE CO., LTD.: EXPANSIONS, JANUARY 2021–JULY 2025  586

TABLE 820            IQVIA INC.: COMPANY OVERVIEW            588

TABLE 821            IQVIA INC.: SERVICES OFFERED 589

TABLE 822            ALMAC GROUP: COMPANY OVERVIEW 590

TABLE 823            ALMAC GROUP: SERVICES OFFERED      590

TABLE 824            CEGAT GMBH: COMPANY OVERVIEW    591

TABLE 825            CEGAT GMBH: SERVICES OFFERED         591

TABLE 826            ACTIVE MOTIF: COMPANY OVERVIEW  592

TABLE 827            ACTIVE MOTIF: SERVICES OFFERED       592

TABLE 828            SINGLERON BIOTECHNOLOGIES: COMPANY OVERVIEW          593

TABLE 829            CELL MICROSYSTEMS: COMPANY OVERVIEW                 594

TABLE 830            NANOCELLECT BIOMEDICAL: COMPANY OVERVIEW          595

TABLE 831            OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW   596

TABLE 832            REVVITY: COMPANY OVERVIEW               597

TABLE 833            PARSE BIOSCIENCES: COMPANY OVERVIEW                 598

TABLE 834            ULTIMA GENOMICS: COMPANY OVERVIEW                 599

TABLE 835            MISSION BIO: BUSINESS OVERVIEW        600

TABLE 836            SINGLE CELL DISCOVERIES BV: COMPANY OVERVIEW          601

TABLE 837            ADMERA HEALTH: COMPANY OVERVIEW                 602

TABLE 838            BGI: COMPANY OVERVIEW          603

TABLE 839            SIGNIOSBIO: COMPANY OVERVIEW        604

TABLE 840            MACROGEN CO., LTD.: COMPANY OVERVIEW                 605

TABLE 841            LEXOGEN GMBH: COMPANY OVERVIEW                 606

TABLE 842            DISCOVERY LIFE SCIENCES: COMPANY OVERVIEW          607

TABLE 843            CELLCARTA: COMPANY OVERVIEW        608

TABLE 844            SINGULOMICS CORPORATION: COMPANY OVERVIEW          609

TABLE 845            SEQMATIC LLC.: COMPANY OVERVIEW 610

LIST OF FIGURES

FIGURE 1              SINGLE-CELL SEQUENCING MARKET: MARKETS & REGIONS COVERED    53

FIGURE 2              REGIONAL SEGMENTATION       54

FIGURE 3              YEARS CONSIDERED      56

FIGURE 4              RESEARCH DESIGN METHODOLOGY      57

FIGURE 5              SINGLE-CELL SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS               59

FIGURE 6              SINGLE-CELL SEQUENCING MARKET SIZE ESTIMATION, 2024           60

FIGURE 7              GLOBAL MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024     61

FIGURE 8              ILLUSTRATIVE EXAMPLE OF 10X GENOMICS: REVENUE ANALYSIS (2024)           61

FIGURE 9              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             63

FIGURE 10            SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH          63

FIGURE 11            SINGLE-CELL SEQUENCING MARKET: CAGR PROJECTIONS, 2025−2030             66

FIGURE 12            SINGLE-CELL SEQUENCING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS           67

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 69

FIGURE 14            SINGLE-CELL SEQUENCING MARKET, BY OFFERING,

2025 VS. 2030 (USD MILLION)      72

FIGURE 15            SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY TYPE,

2025 VS. 2030 (USD MILLION)      73

FIGURE 16            SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024  73

FIGURE 17            SINGLE-CELL SEQUENCING SERVICES MARKET, BY TYPE,

2025 VS. 2030 (USD MILLION)      74

FIGURE 18            SINGLE-CELL SEQUENCING MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      75

FIGURE 19            SINGLE-CELL SEQUENCING MARKET, BY SEQUENCING TYPE,

2025 VS. 2030 (USD MILLION)      75

FIGURE 20            SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      76

FIGURE 21            SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      77

FIGURE 22            GEOGRAPHIC SNAPSHOT OF SINGLE-CELL SEQUENCING MARKET 78

FIGURE 23            ADVANCEMENTS IN SINGLE-CELL SEQUENCING TECHNOLOGIES

TO PROPEL MARKET      81

FIGURE 24            PRODUCTS SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2024             82

FIGURE 25            CANCER RESEARCH APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024       82

FIGURE 26            PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024   83

FIGURE 27            BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024   83

FIGURE 28            ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD       84

FIGURE 29            SINGLE-CELL SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         85

FIGURE 30            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           94

FIGURE 31            SINGLE-CELL SEQUENCING MARKET: VALUE CHAIN ANALYSIS              95

FIGURE 32            SINGLE-CELL SEQUENCING MARKET: ECOSYSTEM ANALYSIS  96

FIGURE 33            PATENT APPLICATIONS IN SINGLE-CELL SEQUENCING MARKET,

JANUARY 2014–DECEMBER 2024 102

FIGURE 34            SINGLE-CELL SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 108

FIGURE 35            AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024  119

FIGURE 36            AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024     120

FIGURE 37            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR

SINGLE-CELL SEQUENCING PRODUCTS                121

FIGURE 38            KEY BUYING CRITERIA FOR END USERS                 123

FIGURE 39            AI-USE CASES    128

FIGURE 40            NORTH AMERICA: SINGLE-CELL SEQUENCING MARKET SNAPSHOT       294

FIGURE 41            NIH FUNDING FOR STEM CELL RESEARCH, 2015–2025        302

FIGURE 42            ASIA PACIFIC: SINGLE-CELL SEQUENCING MARKET SNAPSHOT       366

FIGURE 43            REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-CELL SEQUENCING

MARKET, 2022–2024          496

FIGURE 44            MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024        497

FIGURE 45            SINGLE-CELL SEQUENCING PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 501

FIGURE 46            SINGLE-CELL SEQUENCING PRODUCT MARKET: COMPANY FOOTPRINT             502

FIGURE 47            SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024  509

FIGURE 48            SINGLE-CELL SEQUENCING SERVICES MARKET: COMPANY FOOTPRINT 510

FIGURE 49            SINGLE-CELL SEQUENCING MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024                 514

FIGURE 50            EV/EBITDA OF KEY VENDORS   518

FIGURE 51            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                518

FIGURE 52            SINGLE-CELL SEQUENCING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     519

FIGURE 53            BD: COMPANY SNAPSHOT (2024)              525

FIGURE 54            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)             532

FIGURE 55            DANAHER CORPORATION: COMPANY SNAPSHOT (2024)             537

FIGURE 56            10X GENOMICS: COMPANY SNAPSHOT (2024)                 542

FIGURE 57            ILLUMINA, INC.: COMPANY SNAPSHOT (2024)                 549

FIGURE 58            MERCK KGAA: COMPANY SNAPSHOT (2024)                 555

FIGURE 59            QIAGEN N.V.: COMPANY SNAPSHOT (2024)                 559

FIGURE 60            BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)             562

FIGURE 61            TECAN TRADING AG: COMPANY SNAPSHOT (2024)    566

FIGURE 62            CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2024)    569

FIGURE 63            TAKARA BIO INC.: COMPANY SNAPSHOT (2024)                 573

FIGURE 66            AZENTA US INC.: COMPANY SNAPSHOT (2024)                 583

FIGURE 67            IQVIA INC.: COMPANY SNAPSHOT (2024)                 589

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧